Protein aggregation was recently quantified in lymphoblastoid cell lines from patients with ALS, revealing differences between sporadic and genetic forms.16 Specific drug candidates, including protein kinase inhibitors, reduced aggregation in sALS lymphoblasts but showed limited effects in genetic ALS, emphasizing disease heterogeneity. Here, WEE1 is linked to amyotrophic lateral sclerosis.